CenTrial Logo

Clinical Study examines the Risk Factors for Failure of Glaucoma Surgery

by


Clinical study determines tube shunt surgery risky for some glaucoma patients

clinical study investigates the potential risk factors for failure of tube shunt surgery in glaucoma patients.

Glaucoma is a common eye condition where the optic nerve, which connects the eye to the brain, becomes damaged. It is usually caused by the build-up of fluid in the front part of the eye, which increases the pressure inside the eye. If not treated promptly glaucoma can lead to loss of vision.

Tube shunt surgery is a common procedure used to treat glaucoma. This procedure uses a tube shunt, which is a flexible glaucoma drainage device that is implanted in the eye to drain the eye fluid from the inside of the eye to an external reservoir. Glaucoma tube shunt surgery may be needed to lower eye pressure in patients when medications, laser, or other surgery has not worked.

Tube shunt surgery is an effective treatment option for glaucoma patients but there are concerns about tube blockage and failure of this procedure.

A clinical study has identified several risk factors that can increase the chances of failure of tube shunt surgery. The study, which pooled data from three previously performed clinical trials, involved 621 patients with medically uncontrolled glaucoma who underwent tube shunt surgery. The failure rate of this surgery was calculated and the risk factors associated with shunt failure were identified.

The study found that the overall risk of surgical failure was 38.3% after 5 years. There were several factors were associated with a higher risk of failure, including younger age, neovascular glaucoma, lower preoperative eye pressure, and a special surgical technique called the Ahmed implantation.

Are you interested in clinical trials near you?

You can receive free notification of a trial for this, or any other condition, by completing a short confidential health profile.
Find a clinical trial near me
A pre-surgical eye pressure of less than 21 was associated with a higher failure rate. Younger age was also found to be a risk factor for failure of tube shunt surgery. This is because younger patients tend to have more active and aggressive forms of glaucoma, which can be more difficult to manage with surgery.

Certain types of glaucoma were also found to be associated with a higher risk of failure of tube shunt surgery. Specifically, patients with neovascular glaucoma, a type of glaucoma that is caused by the growth of new blood vessels in the eye, were found to have a significantly higher risk of failure.

The clinical study also found that the type of tube shunt used in the surgery, called the Ahmed glaucoma valve, also negatively affected the surgical outcomes. So, what can be concluded from the clinical study?

Overall, this clinical study provides important insights into the risk factors associated with the failure of tube shunt surgery for glaucoma. By identifying these risk factors, ophthalmologists can better identify patients who may be at a higher risk of complications from the procedure and adjust their treatment plans accordingly. Patients who are considering tube shunt surgery should discuss the potential benefits and risks of the procedure with their ophthalmologist and make an informed decision based on their individual circumstances.
__________                               



Share this article with a friend:
     


Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

Signup to be notified of clinical trials near you that match your condition

Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.


This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.